金新農(002548.SZ)預計上半年淨利潤增長854.48%-1028.02%
格隆匯7月12日丨金新農(002548.SZ)公佈,2020年1月1日至2020年6月30日,公司預計歸屬於上市公司股東的淨利潤16,500萬元-19,500萬元,比上年同期增長854.48%-1,028.02%。
報告期內,歸屬於上市公司股東的淨利潤大幅增長主要系養殖業務盈利能力提升。受“非洲豬瘟”疫情的影響,國內生豬產能大幅下降,豬肉市場供需矛盾突出,市場生豬價格同比大幅上漲,公司2020年上半年生豬銷售均價較上年同期增長195.63%,受此影響公司業績較去年同期有大幅度的增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.